XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | (FY)Aug 31, 2020 | (Q6)Feb 29, 2020 | (FY)Aug 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -30.44%28.57M | 2.79%57.59M | 12.96%41.07M | 7.71%56.03M | 19.08%36.35M | 11.47%52.01M | -8.41%30.53M | -34.04%46.66M | -19.82%33.33M | 24.88%70.74M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -248.84%-450K | -296.97%-262K | -437.50%-129K | 70.80%-66K | 78.18%-24K | -18.32%-226K | 21.43%-110K | 59.62%-191K | 43.32%-140K | -27.15%-473K |
Investment loss (gain) | ---- | ---- | ---- | ---516K | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | --10K | --118K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 128.52%79K | 128.52%79K | -291.03%-277K |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 126.78%79K | 126.78%79K | -278.79%-295K |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 190.00%18K |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---170K | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---170K | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---775K | --206K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16K |
-Loss (gain) on sale of property, machinery and equipment | ---- | --206K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16K |
-Loss (gain) from selling other assets | ---775K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | 14.95%27.64M | 22.68%51.24M | 25.68%24.05M | 11.25%41.77M | 30.29%19.14M | 39.32%37.54M | 7.18%14.69M | 35.08%26.95M | 25.96%13.7M | 1.16%19.95M |
-Amortization of intangible assets | 41.29%852K | -22.00%1.35M | 4.51%603K | -8.94%1.73M | -17.57%577K | 66.55%1.9M | 49.57%700K | 144.02%1.14M | 81.40%468K | -25.24%468K |
Financial expense | 193.02%19.55M | -0.76%6.93M | 55.71%6.67M | -47.77%6.98M | -36.52%4.29M | 313.97%13.37M | --6.75M | --3.23M | ---- | ---- |
Special items | ---- | ---- | ---- | ---- | ---- | --2.3M | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | 4.03%74.55M | 11.16%115.82M | 20.27%71.66M | -0.77%104.19M | 14.89%59.58M | 36.85%105M | 10.39%51.86M | -14.71%76.72M | -9.54%46.98M | 18.14%89.96M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.61%7.01M | 53.90%7.01M | -25.95%7.35M |
Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -106.00%-41K | -105.93%-41K | -72.58%683K |
Accounts payable increase (decrease) | 545.42%26.51M | 188.97%12.02M | 114.84%4.11M | 21.03%-13.51M | -22.83%-27.68M | -264.42%-17.1M | -565.62%-22.54M | 59.70%10.4M | 139.76%4.84M | 128.34%6.51M |
prepayments (increase)decrease | -225.04%-12.47M | 299.56%17.86M | 2,650.90%9.97M | -152.64%-8.95M | -101.88%-391K | 154.59%17M | 428.64%20.82M | -5,948.35%-31.15M | -1,775.66%-6.33M | 82.62%-515K |
Special items for working capital changes | -92.15%-164.12M | 44.59%72.98M | -35.81%-85.41M | -24.95%50.47M | -5,076.21%-62.89M | 349.20%67.26M | 97.80%-1.22M | -181.60%-26.99M | -61.98%-55.26M | 393.69%33.07M |
Cash from business operations | -23,199.08%-75.53M | 65.40%218.68M | 101.04%327K | -23.20%132.21M | -164.15%-31.38M | 378.79%172.16M | 1,841.62%48.92M | -73.77%35.96M | -124.93%-2.81M | 166.91%137.06M |
Other taxs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -709.98%-4.3M | -2,357.71%-4.3M | -43.13%-531K |
Interest received - operating | 248.84%450K | 296.97%262K | 437.50%129K | -70.80%66K | -78.18%24K | 18.32%226K | -21.43%110K | -59.62%191K | -43.32%140K | 27.15%473K |
Net cash from operations | -16,565.79%-75.08M | 65.52%218.94M | 101.45%456K | -23.27%132.27M | -163.96%-31.36M | 441.28%172.38M | 803.47%49.03M | -76.75%31.85M | -161.47%-6.97M | 166.79%137M |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | ---- | --123K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | 61.56%-33.62M | -27.15%-131.94M | -3.60%-87.48M | 48.50%-103.77M | 42.11%-84.44M | -30.57%-201.48M | -22.77%-145.86M | -18.22%-154.31M | -76.91%-118.81M | -246.57%-130.53M |
Purchase of intangible assets | 42.42%-1.25M | 46.15%-3.07M | -78.68%-2.17M | -287.08%-5.69M | -32.07%-1.22M | 52.36%-1.47M | 62.26%-920K | -174.00%-3.09M | -420.94%-2.44M | -390.00%-1.13M |
Acquisition of subsidiaries | ---- | ---500K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | --8.75M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 63.55%-3M | ---- | ---8.23M | ---8.09M | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.24M | ---1.24M | ---- |
Net cash from investment operations | 61.10%-34.87M | -27.02%-138.38M | 4.37%-89.65M | 46.32%-108.94M | 36.13%-93.75M | -27.94%-202.96M | -19.83%-146.78M | -20.50%-158.64M | -81.13%-122.49M | -247.44%-131.65M |
Net cash before financing | -23.28%-109.96M | 245.28%80.55M | 28.71%-89.19M | 176.31%23.33M | -27.99%-125.11M | 75.89%-30.57M | 24.49%-97.75M | -2,471.25%-126.79M | -130.00%-129.46M | -60.27%5.35M |
Cash flow from financing activities | ||||||||||
New borrowing | -29.28%124.2M | -40.66%246.43M | 202.95%175.62M | 987.17%415.3M | 189.85%57.97M | -68.36%38.2M | 179.72%20M | 131.58%120.73M | -83.91%7.15M | -6.44%52.13M |
Refund | -34.28%-163.03M | 38.34%-274.31M | -50.66%-121.41M | -463.17%-444.85M | -79.12%-80.58M | 62.94%-78.99M | 27.57%-44.99M | -143.97%-213.16M | -42.99%-62.11M | -45.22%-87.37M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --313.49M | ---- | ---- |
Interest paid - financing | -52.91%-25.4M | 4.05%-38.64M | 33.06%-16.61M | -33.94%-40.27M | -83.60%-24.81M | -1.16%-30.07M | -1.44%-13.51M | -120.34%-29.72M | -87.59%-13.32M | 16.62%-13.49M |
Dividends paid - financing | ---- | ---63.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---21M | ---- | ---- |
Other items of the financing business | 5,838.80%233.68M | 605.86%64.93M | -120.93%-4.07M | -117.90%-12.84M | -61.93%19.46M | -53.86%71.71M | -41.68%51.11M | 129.32%155.42M | --87.63M | --67.78M |
Net cash from financing operations | 405.33%169.46M | 20.69%-65.55M | 219.90%33.53M | -9,823.53%-82.65M | -321.87%-27.97M | -99.74%850K | -34.84%12.61M | 1,610.39%325.76M | 417.22%19.35M | 192.34%19.05M |
Effect of rate | 31.11%4.42M | -68.31%2.69M | 794.43%3.37M | 317.37%8.47M | 105.80%377K | -47.15%-3.9M | ---6.5M | ---2.65M | ---- | ---- |
Net Cash | 206.90%59.5M | 125.29%15M | 63.64%-55.66M | -99.58%-59.32M | -79.79%-153.07M | -114.94%-29.72M | 22.68%-85.14M | 715.68%198.97M | -76.50%-110.11M | 440.30%24.39M |
Begining period cash | 6.99%270.78M | -16.73%253.09M | -16.73%253.09M | -9.96%303.93M | -9.96%303.93M | 139.00%337.55M | 139.00%337.55M | 20.88%141.23M | 20.88%141.23M | -5.78%116.84M |
Cash at the end | 66.68%334.7M | 6.99%270.78M | 32.77%200.8M | -16.73%253.09M | -38.50%151.24M | -9.96%303.93M | 690.11%245.92M | 139.00%337.55M | -42.85%31.12M | 20.88%141.23M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | -9.96%303.93M | ---- | 141.23%337.55M | ---- | 19.76%139.93M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | -9.96%303.93M | ---- | 141.23%337.55M | ---- | 19.76%139.93M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.